Search alternatives:
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
greatest decrease » treatment decreased (Expand Search), greater increase (Expand Search)
genes decrease » teer decrease (Expand Search), sizes decrease (Expand Search), levels decreased (Expand Search)
significant decrease » significant increase (Expand Search), significantly increased (Expand Search)
greatest decrease » treatment decreased (Expand Search), greater increase (Expand Search)
genes decrease » teer decrease (Expand Search), sizes decrease (Expand Search), levels decreased (Expand Search)
-
3041
Verification of PLUS CYCLE<sup>®</sup> signals during presumed sleep periods.
Published 2025Subjects: -
3042
-
3043
-
3044
The characteristics of patient groups were used to prove the method’s applicability.
Published 2025Subjects: -
3045
-
3046
-
3047
ROS, K<sup>+</sup> efflux and cathepsin B are required for NLRP3 activation.
Published 2025Subjects: -
3048
-
3049
Differences in health-related quality of life indexes after disease onset between groups.
Published 2025Subjects: -
3050
Changes in subcutaneous fat thickness and muscle mass (Approximately here).
Published 2025Subjects: -
3051
-
3052
-
3053
-
3054
-
3055
-
3056
-
3057
-
3058
Characteristics and outcomes from clams with MarBTN and control healthy clams.
Published 2025Subjects: -
3059
-
3060